CClinicalTrials.gg
RecruitingNCT07775781Updated Aug 20, 2026

Effectiveness of Implementing a Reablement Model in Community-Based Long-Term Care Centers

An interventional study of Reablement intervention in Elderly, Long-Term Care and Reablement, sponsored by National Taiwan University Hospital. Recruiting at 8 sites in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will examine whether a reablement approach can help people receiving community-based long-term care maintain or improve their independence, daily functioning, and quality of life. Approximately 300 adults from eight long-term care facilities across Taiwan will participate. The 12-week reablement program includes group and individualized activities designed to support mobility, cognitive function, daily activities, and social participation. Participants' physical and cognitive function, daily living abilities, emotional well-being, quality of life, and personal goals will be assessed before and after the program.

The study will also include observations and interviews with care providers, participants, and family members to understand their experiences with the program and identify factors that support successful implementation. The findings are expected to help develop a practical reablement model for community-based long-term care in Taiwan and provide guidance for improving care quality, independence, and healthy aging.

Read the detailed description

This study adopts a mixed-methods design, incorporating both quantitative and qualitative components. The quantitative component employs a quasi-experimental design and is expected to recruit approximately 300 adults aged 18 years or older with long-term care needs from eight community-based long-term care facilities across northern, central, and southern Taiwan. Facilities will be assigned to either an experimental group or a wait-list control group. The experimental group will receive a 12-week reablement intervention, while the control group will initially receive usual care and subsequently receive the same intervention. The reablement intervention consists of group activities (once weekly, 30 minutes per session) and individualized activities (at least twice weekly, 15-30 minutes per session), addressing mobility, cognitive function, activities of daily living, and social participation. Outcomes will be assessed before and after the intervention, including mobility (SPPB), cognitive function (BHT-7), activities of daily living (Barthel Index and IADL), depressive symptoms (GDS-5), neuropsychiatric symptoms (NPI-Q), quality of life (SF-12, EQ-VAS, and Life Satisfaction Scale), and individualized goal attainment, to evaluate the effectiveness of the reablement model.

The qualitative component will employ the extended case method, with the eight day care facilities serving as the research settings. Through field observations, document analysis, and semi-structured interviews with approximately 50 facility staff members, service users, and family caregivers, the study will explore in depth the implementation process, influencing factors, and practical strategies associated with introducing the reablement model into real-world care settings. Qualitative data will be analyzed using thematic analysis to develop a reablement service model and practical implementation principles tailored to the context of community-based long-term care in Taiwan.

This study is expected to establish a locally applicable reablement service model for community-based long-term care and provide empirical evidence to support policy development and improvements in service quality. The findings may also serve as a practical reference for long-term care facilities seeking to implement reablement-oriented care, thereby promoting the maintenance of functional abilities, improving quality of life, and supporting healthy aging among older adults.

02

Conditions studied

  • Elderly
  • Long-Term Care
  • Reablement
  • Activities of Daily Living

Keywords

  • reablement
  • activities of daily living
  • long-term care
  • daycare center
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 18 years or older and assessed as CMS Level 2 or above.
  • Regularly receiving adult day care services and attending at least two days per week.
  • Able to understand simple instructions and participate in activities with assistance.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment or severe visual or hearing impairment that interferes with participation in activities or assessments.
  • A major fall within the past three months or acute symptoms that prevent participation in assessments or study procedures.
  • Concurrent participation in another intensive rehabilitation program or research intervention.
  • Clear unwillingness to participate in the study intervention or inability to complete the three-month intervention period.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Reablement Group

    The experimental group will first receive a 12-week reablement intervention, consisting of both group and individualized activities.

    Behavioral: Reablement intervention

  • No intervention
    Waiting List Control Group

    The control group (wait-list control group) will first receive 12 weeks of usual care, followed by the same reablement intervention provided to the experimental group. Usual care will consist of routine activities provided by the adult day care centers, including stretching and muscle-strengthening exercises, group-based cognitive and craft activities, individualized activities, lunch, and scheduled rest periods.

Interventions

  • BehavioralReablement intervention

    Reablement intervention consists group activities and individualized activities. Group activities will be conducted once a week for 30 minutes per session. The activities will focus on mobility, cognition and emotional well-being, independence in activities of daily living, and social participation. Healthcare professionals will design practical and engaging activities based on everyday life situations. Individualized activities will be conducted for 15-30 minutes per session, at least twice a week. Healthcare professionals will develop individualized activities that can be incorporated into participants' daily routines based on their functional abilities, personal interests, and available facility resources.

05

What researchers measure

Primary outcomes

  1. Mobility - Short Physical Performance Battery (SPPB)

    The SPPB assesses lower-extremity physical performance in older adults and comprises three major components: static balance, gait speed, and lower-extremity strength. Total scores range from 0 to 12, with higher scores indicating better physical function.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  2. Cognition - Brain Health Test-7 (BHT-7)

    The BHT-7 was developed from the cognitive assessment component of the original BHT-cog. It includes assessments of time orientation, five-item immediate and delayed recall, categorical verbal fluency, cube copying, clock drawing, and the three-step Luria test, with a total score of 23 points. The BHT-7 can be used to identify individuals with mild cognitive impairment and dementia, with cutoff scores of 17/18 and 14/15, respectively. The BHT-7 also maintains good screening performance among individuals with higher levels of education.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  3. Basic Activities of Daily Living - Barthel Index (BI)

    The Barthel Index measures functional independence in performing basic activities of daily living. It comprises 10 items covering feeding, bathing, grooming, dressing, bowel control, bladder control, toileting, transfers, mobility, and stair climbing. Items are scored according to the participant's level of independence, typically as 0, 5, 10, or 15 points. Total scores range from 0 to 100, with higher scores indicating greater functional independence.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  4. Instrumental Activities of Daily Living - Lawton Instrumental Activities of Daily Living Scale (Lawton IADL Scale)

    The Lawton IADL Scale assesses independence in instrumental activities of daily living (IADL) among older adults. The scale includes eight activities: telephone use, shopping, food preparation, housekeeping, laundry, transportation, medication management, and financial management. The traditional version uses dichotomous scoring (0-8 points); however, modified versions employ three- or four-level scoring systems according to the degree of independence, with each item scored from 0 to 4 and total scores ranging from 0 to 24. Higher scores indicate better functional performance. The present study will use the 24-point version to provide greater sensitivity in detecting intervention effects.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  5. BPSD - Neuropsychiatric Inventory-Questionnaire (NPI-Q)

    The NPI-Q is used to assess the severity of neuropsychiatric symptoms experienced by individuals with dementia during the previous month, as well as the level of distress these symptoms cause their caregivers. It covers 12 neuropsychiatric symptoms, including delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, nighttime behavioral disturbances, and appetite/eating disturbances. Each symptom is rated for severity on a 0-3 scale, with higher scores indicating greater symptom severity, and for caregiver distress on a 0-5 scale, with higher scores indicating greater caregiver distress.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  6. Depression - Geriatric Depression Scale 5 (GDS-5)

    The GDS-5 is used to assess the severity of depressive symptoms in participants. It consists of five items, with a total score ranging from 0 to 5. Higher scores indicate greater severity of depressive symptoms.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  7. Quality of Life - World Health Organization-Five Well-Being Index (WHO-5)

    The WHO-5 is a self-report instrument measuring mental well-being. It consists of five statements relating to the past two weeks. Each statement is rated on a 6-point scale, with higher scores indicating better mental well-being.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

  8. Quality of Life - EurolQoL (VAS)

    The EQ-VAS is used to assess participants' self-rated health status. It consists of a vertical scale with endpoints labeled "the best health you can imagine" and "the worst health you can imagine." Participants are asked to mark an "X" on the scale to indicate their health status on the day of assessment. Higher scores indicate better perceived health status.

    Time frame: For intervention group: from enrollment to the end of treatment at 12 weeks For control group: from enrollment to the end of treatment at 24 weeks

06

Study locations

8 of 8 sites recruiting
  • Xu-An Daycare Center
    Kaohsiung City, Taiwan
    Recruiting
  • Puli Christian Hospital
    Nantou City, Taiwan
    Recruiting
  • Rong-Guang Daycare Center
    Nantou City, Taiwan
    • Wang · Contact · +886492990833
    Recruiting
  • Fu-Zhong Daycare Center
    New Taipei City, Taiwan
    Recruiting
  • Da-She Daycare Center
    Tainan, Taiwan
    Recruiting
  • Adlers Donghu Elementary School Community-Based Long-Term Care Facility
    Taipei, Taiwan
    Recruiting
  • Kang-He Daycare Center
    Taipei, Taiwan
    Recruiting
  • Qi-Yan Community-Based Long-Term Care Facility
    Taipei, Taiwan
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07775781
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Aug 20, 2026
Start date
Jul 1, 2026
Primary completion
Jul 1, 2026
Completion
Dec 2028 (estimated)
Last update
Aug 20, 2026

Study contacts

Hui-fun Mao, Professor
Contact
huifen@ntu.edu.tw
+886233668178

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion